Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(38%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
2
25%
Ph phase_2
1
13%
Ph early_phase_1
1
13%
Ph phase_3
3
38%

Phase Distribution

3

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 33 (37.5%)
N/A1 (12.5%)

Trials by Status

not_yet_recruiting113%
recruiting225%
unknown113%
completed338%
active_not_recruiting113%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_3

Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser

NCT05916963
active_not_recruitingphase_1

Salt-Sensitivity and Immunity Cell Activation

NCT03753204
not_yet_recruitingphase_3

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

NCT06407401
recruitingphase_2

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

NCT06252454
completednot_applicable

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

NCT04982874
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05916963Phase 3

Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser

Recruiting
NCT03753204Phase 1

Salt-Sensitivity and Immunity Cell Activation

Active Not Recruiting
NCT06407401Phase 3

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Not Yet Recruiting
NCT06252454Phase 2

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

Recruiting
NCT04982874Not Applicable

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Completed
NCT05270421Phase 3

Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi

Unknown
NCT03837470Early Phase 1

Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction

Completed
NCT02028689Phase 1

Metformin and Furosemide Drug-Drug Interaction Study

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8